Drug Shortage Report for MYLAN-NIFEDIPINE EXTENDED RELEASE
| Report ID | 36919 |
| Drug Identification Number | 02349167 |
| Brand name | MYLAN-NIFEDIPINE EXTENDED RELEASE |
| Common or Proper name | MYLAN-NIFEDIPINE EXTENDED RELEASE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | NIFEDIPINE |
| Strength(s) | 30MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 BT |
| ATC code | C08CA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2018-12-24 |
| Actual start date | 2018-12-10 |
| Estimated end date | 2020-01-05 |
| Actual end date | 2020-01-08 |
| Shortage status | Resolved |
| Updated date | 2020-01-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v93 | 2020-01-09 | French | Compare |
| v92 | 2020-01-09 | English | Compare |
| v91 | 2019-10-29 | French | Compare |
| v90 | 2019-10-29 | English | Compare |
| v89 | 2019-10-08 | French | Compare |
| v88 | 2019-10-08 | English | Compare |
| v87 | 2019-01-18 | French | Compare |
| v86 | 2019-01-18 | English | Compare |
| v85 | 2019-01-08 | French | Compare |
| v84 | 2019-01-08 | English | Compare |
| v83 | 2018-12-19 | French | Compare |
| v82 | 2018-12-19 | English | Compare |
| v81 | 2018-12-12 | French | Compare |
| v80 | 2018-12-12 | English | Compare |
| v79 | 2018-11-21 | English | Compare |
| v78 | 2018-11-20 | French | Compare |
| v77 | 2018-11-20 | English | Compare |
| v76 | 2018-11-13 | French | Compare |
| v75 | 2018-11-13 | English | Compare |
| v74 | 2018-10-23 | French | Compare |